Issue : 21 January 2008
View all stories from this issue.
Low levels of vitamin E are associated with physical decline in among older people, according to a study.
Simvastatin tablets recalledSubscription
A batch of Simvastatin tablets have been recalled by their manufacturer because of incorrect labelling.
A saline nasal wash solution made from processed sea water could be used to treat children with colds, a study has shown.
Nurses are 'better' than GPs at prescribingSubscription
Nurse prescribers are much better than doctors at following prescribing guidelines, say senior NHS managers.
Report highlights health visitor crisisSubscription
MPs have been told of the ‘tragedy’ of health inequalities in a report published today.
Nurses could be taught melanoma screeningSubscription
A screening system using multiple observers could be used as a tool to identify malignant melanomas, a study has found.
Diabetes drug indication extendedSubscription
The European Commission has expanded the indication of the type 2 diabetes drug sitagliptin (Januvia).
New add-on therapy for kidney cancerSubscription
An add-on therapy for treating kidney cancer patients has been launched in the UK.
Novel plaster that delivers pain reliefSubscription
A novel plaster that delivers anaesthetics, the first of its kind, has been launched in the UK.Raydan combines an innovative gentle warming system with two potent anaesthetics, lidocaine and tetracaine, to provide pain management.Its manufacturer, EUSA Pharma, said the system worked twice as fast as topical cream and eliminated pain in 95% of patients after half an hour.The company claim it will help prevent needle phobia in children and free up nursing time.
NHS patients in Wales should have access to a new treatment for chronic myeloid leukaemia (CML), according to the All Wales Medicines Strategy Group.Dasatinib (Sprycel) has been recommended for the treatment of adults with chronic or accelerated phase CML, where there is resistance or intolerance to prior therapy including imatinib mesylate. The drug is an oral tyrosine kinase inhibitor that blocks leukaemia cell growth, enabling adults with certain types of the CML ...